When breakthrough, first-of-their-kind treatments gain approval, the clinical and commercial plans have to be smarter, faster and more flexible. And we think we’re on to something lifechanging for our clients.
Amid a pandemic that has revealed systemic deficiencies, the industry
presses for more diversity in its workforces, research cohorts and communications.
As vaccine distribution slogs along, marketers must face the new tele-frontier.
The Centers for Disease Control and Prevention took a look at exposure rates among college athletes in 17 states.
Did journalists and publishers rise to the occasion? We asked health media and agency execs to perform a mid-pandemic self-evaluation.
The president of Vivo Agency discusses his history in the medical device industry and how it helped shape the agency.
A Q+A with Kara Dugan, president, Razorfish Health, and MM+M general manager and editor-in-chief Steve Madden.
